Search results for: 'Reagents AND China'

The medical imaging market in China has experienced substantial growth, with multinational and local companies competing for higher market share. Medical imaging technology encompasses a wide range of imaging diagnosis methods (computed tomography, magnetic resonance imaging, and ultrasound are the three major market segments). This study presents ...

13 Jul 2017  |  Asia Pacific  |  Market Research

China Medical Imaging Equipment Market, Forecast to 2021

Policies, Disruption, and the Future of Medical Imaging

Infographics

×

The study aims to analyze and forecast the healthcare imaging market in China (2017–2021). Research scope: Market trends, competitive structure, market metrics, market share, revenues, strategy, and government policies and initiatives. Regional scope: China (excluding Hong Kong) The study includes in-depth analysis of government-driven reforms, ...

China Contract Research Organization (CRO) Market

This Frost & Sullivan research service covers the state of the China Healthcare Information Technology Market, examining drivers and restraints for growth, pricing, technology, legislation, demand and geographical trends. In addition, an in-depth analysis of the competitive situation is performed. The market is further divided into two sub segment...

This research service analyses the IVD in China, strategically, by evaluating the various forces that are currently shaping this market. It analyses the revenue potential for the key segments in this market, namely, clinical chemistry, immunoassay, hematology, coagulation, microbiology, molecular diagnostics, SMBG and point-of-care testing and fore...

The IVD market in China presents diversified growth potential for different tiers of participants: domestic participants stand to gain from the growth momentum in the lower-end market, whereas foreign leading manufacturers dominate the high-end market. This research service analyzes the IVD market and provides forecasts and opportunities by underst...

The Chinese wound care market is in the growth stage. Growing ageing population and rise in the incidence of lifestyle diseases, coupled with the increase in risk of chronic wounds and in affordability of better quality of wound care products provide the impetus for the Chinese wound care market. Universal coverage of public health insurance scheme...

The In-vitro Diagnostics (IVD) market in China shows strong growth potential in several segments. Market growth is set to be driven by the growing volume of tests, rather than the higher price of testing solutions in traditional segments and the popularization of advanced testing technology in emerging segments. In the context of the reform in publ...

The study covers the eHealth initiatives across the emerging markets in Asia-Pacific. Government initiatives and incentives that encourage technology adoption in healthcare are key drivers for private sector investment in the Asia-Pacific eHealth industry. However, inadequate infrastructure and regulatory framework development have adversely affect...